<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02753127</url>
  </required_header>
  <id_info>
    <org_study_id>CanStem303C</org_study_id>
    <secondary_id>BB608-303CRC</secondary_id>
    <secondary_id>2016-001627-31</secondary_id>
    <nct_id>NCT02753127</nct_id>
  </id_info>
  <brief_title>A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer</brief_title>
  <acronym>CanStem303C</acronym>
  <official_title>A Phase III Study of BBI-608 in Combination With 5-Fluorouracil, Leucovorin, Irinotecan (FOLFIRI) in Adult Patients With Previously Treated Metastatic Colorectal Cancer (CRC).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Biomedical, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Biomedical, Inc</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an international multi-center, prospective, open-label, randomized phase 3 trial of
      the cancer stem cell pathway inhibitor napabucasin plus standard bi-weekly FOLFIRI versus
      standard bi-weekly FOLFIRI in patients with previously treated metastatic colorectal cancer
      (CRC).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <primary_completion_date type="Anticipated">June 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>36 months</time_frame>
    <description>To assess the effect of napabucasin plus biweekly FOLFIRI versus biweekly FOLFIRI on the Overall Survival of patients with previously treated metastatic colorectal cancer.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Progression Free Survival</measure>
    <time_frame>36 months</time_frame>
    <description>Defined as the time from randomization to the first objective documentation of disease progression or death due to any cause.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Objective Response Rate</measure>
    <time_frame>36 months</time_frame>
    <description>Defined as the proportion of patients with a documented complete response or partial response (CR + PR) based on RECIST 1.1.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease Control Rate</measure>
    <time_frame>36 months</time_frame>
    <description>Defined as the proportion of patients with a documented complete response, partial response, and stable disease (CR + PR + SD) based on RECIST 1.1.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients with Adverse Events</measure>
    <time_frame>36 months</time_frame>
    <description>All patients who have received at least one dose of napabucasin will be included in the safety analysis according to the National Cancer Institute Common Toxicity Criteria for Adverse Events (NCI CTCAE) version 4.0. The incidence of adverse events will be summarized by type of adverse event and severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (QoL)</measure>
    <time_frame>36 months</time_frame>
    <description>QoL will be measured using the European Organization for Research and Treatment of Cancer Quality of Life questionnaire (EORTC-QLQ-C30) in patients with pretreated metastatic CRC treated with napabucasin plus biweekly FOLFIRI versus biweekly FOLFIRI.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1250</enrollment>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>Napabucasin plus FOLFIRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Addition of bevacizumab to the FOLFIRI regimen will be permissible. FOLFIRI chemotherapy infusion will start at least 2 hours following the first daily dose of napabucasin and will be administered every 2 weeks. Irinotecan/leucovorin infusion will follow bevacizumab infusion in selected patients to receive standard dose of bevacizumab (5 mg/kg). Irinotecan 180 mg/m^2 together with leucovorin 400 mg/m^2 will be administered intravenously, over approximately 90 minutes and 2 hours, respectively, starting on Day 1 of Cycle 1, following bevacizumab infusion or at least 2 hours following the first daily dose of napabucasin if bevacizumab is not administered. 5-FU 400 mg/m^2 bolus will be administered intravenously immediately following irinotecan/leucovorin infusion, followed by 5-FU 1200 mg/m^2/day (total 2400 mg/m^2) continuous infusion. This regimen will be repeated on Day 1 of every 14 day cycle.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FOLFIRI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Addition of bevacizumab to the FOLFIRI regimen will be permissible. FOLFIRI chemotherapy infusion will be administered every 2 weeks. Irinotecan/leucovorin infusion will follow bevacizumab infusion in selected patients to receive standard dose of bevacizumab (5 mg/kg). Irinotecan 180 mg/m^2 together with leucovorin 400 mg/m^2 will be administered intravenously, over approximately 90 minutes and 2 hours, respectively, starting on Day 1 of Cycle 1, following bevacizumab infusion. 5-FU 400 mg/m^2 bolus will be administered intravenously immediately following irinotecan/leucovorin infusion, followed by 5-FU 1200 mg/m^2/day (total 2400 mg/m^2) continuous infusion. This regimen will be repeated on Day 1 of every 14 day cycle.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Napabucasin</intervention_name>
    <description>Napabucasin 240 mg will be administered orally, twice daily, with doses separated by approximately 12 hours (480 mg total daily dose).</description>
    <arm_group_label>Napabucasin plus FOLFIRI</arm_group_label>
    <other_name>BBI-608</other_name>
    <other_name>BBI608</other_name>
    <other_name>BB608</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluorouracil</intervention_name>
    <arm_group_label>Napabucasin plus FOLFIRI</arm_group_label>
    <arm_group_label>FOLFIRI</arm_group_label>
    <other_name>5-FU</other_name>
    <other_name>Carac</other_name>
    <other_name>Efudex</other_name>
    <other_name>Fluoroplex</other_name>
    <other_name>Adrucil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Leucovorin</intervention_name>
    <arm_group_label>Napabucasin plus FOLFIRI</arm_group_label>
    <arm_group_label>FOLFIRI</arm_group_label>
    <other_name>Folinic Acid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Irinotecan</intervention_name>
    <arm_group_label>Napabucasin plus FOLFIRI</arm_group_label>
    <arm_group_label>FOLFIRI</arm_group_label>
    <other_name>Camptosar</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bevacizumab</intervention_name>
    <arm_group_label>Napabucasin plus FOLFIRI</arm_group_label>
    <arm_group_label>FOLFIRI</arm_group_label>
    <other_name>Avastin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Written, signed consent for trial participation must be obtained from the patient
             appropriately in accordance with applicable ICH guidelines and local and regulatory
             requirements prior to the performance of any study specific procedure.

          2. Must have histologically confirmed advanced CRC that is metastatic.

          3. Must have failed treatment with one regimen containing a fluoropyrimidine, oxaliplatin
             with or without bevacizumab for metastatic disease. All patients must have received a
             minimum of 6 weeks of the first-line regimen that included bevacizumab (if
             applicable), oxaliplatin and a fluoropyrimidine in the same cycle. Treatment failure
             is defined as radiologic progression during or &lt; 6 months after the last dose of
             first-line therapy.

          4. FOLFIRI therapy is appropriate for the patient and is recommended by the Investigator.

          5. Imaging investigations including CT/MRI of chest/abdomen/pelvis or other scans as
             necessary to document all sites of disease performed within 21 days prior to
             randomization. Patients with either measurable disease or non-measurable evaluable
             disease are eligible.

          6. Must have an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1.

          7. Must be ≥ 18 years of age.

          8. For male or female patient of child producing potential: Must agree to use
             contraception or take measures to avoid pregnancy during the study and for 180 days
             for female and male patients, of the final FOLFIRI dose. Patients who receive single
             agent napabucasin without FOLFIRI must agree to use contraception or take measures to
             avoid pregnancy during the study and for 30 days for female patients and 90 days for
             male patients, of the final napabucasin dose.

          9. Women of child bearing potential (WOCBP) must have a negative serum or urine pregnancy
             test within 5 days prior to randomization. The minimum sensitivity of the pregnancy
             test must be 25 IU/L or equivalent units of HCG.

         10. Must have alanine transaminase (ALT) ≤ 3 × institutional upper limit of normal (ULN)
             [≤ 5 × ULN in presence of liver metastases] within 14 days prior to randomization.

         11. Must have hemoglobin (Hgb) ≥ 9.0 g/dL within 14 days prior to randomization. Must not
             have required transfusion of red blood cells within 1 week of baseline Hgb assessment.

         12. Must have total bilirubin ≤ 1.5 × institutional ULN [≤ 2.0 x ULN in presence of liver
             metastases] within 14 days prior to randomization.

         13. Must have creatinine ≤ 1.5 × institutional ULN or Creatinine Clearance &gt; 50 ml/min (as
             calculated by the Cockcroft-Gault equation) within 14 days prior to randomization.

         14. Must have absolute neutrophil count ≥ 1.5 x 10^9/L within 14 days prior to
             randomization.

         15. Must have platelet count ≥ 100 x 10^9/L within 14 days prior to randomization. Must
             not have required transfusion of platelets within 1 week of baseline platelet
             assessment.

         16. Patient must have adequate nutritional status with Body Mass Index (BMI) &gt; 18 kg/m^2
             and body weight of &gt; 40 kg with serum albumin &gt; 3 g/dL.

         17. Other baseline laboratory evaluations, listed in Section 6.0, must be done within 14
             days prior to randomization.

         18. Patient must consent to provision of, and Investigator(s) must confirm access to and
             agree to submit a representative formalin fixed paraffin block of tumor tissue in
             order that the specific correlative marker assays may be conducted. Submission of the
             tissue does not have to occur prior to randomization. Where local center regulations
             prohibit submission of blocks of tumor tissue, two 2 mm cores of tumor from the block
             and 10-30 unstained slides of whole sections of representative tumor tissue are
             preferred. Where two 2 mm cores of tumor from the block are unavailable, 10-30
             unstained slides of whole sections of representative tumor tissue alone are
             acceptable. Where no previously resected or biopsied tumor tissue exists or is
             available, on the approval of the Sponsor/designated CRO, the patient may still be
             considered eligible for the study.

         19. Patient must consent to provision of a sample of blood in order that the specific
             correlative marker assays may be conducted.

         20. Patients must be accessible for treatment and follow-up. Patients registered on this
             trial must receive protocol treatment and be followed at the participating center.
             This implies there must be reasonable geographical limits placed on patients being
             considered for this trial. Investigators must ensure that the patients randomized on
             this trial will be available for complete documentation of the treatment, response
             assessment, adverse events, and follow-up.

         21. Protocol treatment is to begin within 2 calendar days of patient randomization.

         22. The patient is not receiving therapy in a concurrent clinical study and the patient
             agrees not to participate in other interventional clinical studies during their
             participation in this trial while on study treatment. Patients participating in
             surveys or observational studies are eligible to participate in this study.

        Exclusion Criteria:

          1. Anti-cancer chemotherapy or biologic therapy if administered prior to the first
             planned dose of study medication (napabucasin or FOLFIRI) within period of time
             equivalent to the usual cycle length of the regimen. An exception is made for oral
             fluoropyrimidines (e.g. capecitabine, S-1), where a minimum of 10 days since last dose
             must be observed prior to the first planned dose of study medication. Standard dose of
             bevacizumab (5 mg/kg) may be administered prior to FOLFIRI infusion, per Investigator
             decision, for as long as permanent decision to include or exclude bevacizumab is made
             prior to patient randomization. Radiotherapy, immunotherapy (including immunotherapy
             administered for non-malignant diseaseneoplastic treatment purposes), or
             investigational agents within four weeks of first planned dose of study medication,
             with the exception of a single dose of radiation up to 8 Gy (equal to 800 RAD) with
             palliative intent for pain control up to 14 days before randomization.

          2. More than one prior chemotherapy regimen administered in the metastatic setting.

          3. Major surgery within 4 weeks prior to randomization.

          4. Patients with any known brain or leptomeningeal metastases are excluded, even if
             treated.

          5. Women who are pregnant or breastfeeding. Women should not breastfeed while taking
             study treatment and for 4 weeks after the last dose of napabucasin or while undergoing
             treatment with FOLFIRI and for 180 days after the last dose of FOLFIRI.

          6. Gastrointestinal disorder(s) which, in the opinion of the Qualified/Principal
             Investigator, would significantly impede the absorption of an oral agent (e.g.
             intestinal occlusion, active Crohn's disease, ulcerative colitis, extensive gastric
             and small intestine resection).

          7. Unable or unwilling to swallow napabucasin capsules daily.

          8. Prior treatment with napabucasin.

          9. Uncontrolled intercurrent illness including, but not limited to, ongoing or active
             infection, clinically significant non-healing or healing wounds, symptomatic
             congestive heart failure, unstable angina pectoris, clinically significant cardiac
             arrhythmia, significant pulmonary disease (shortness of breath at rest or mild
             exertion), uncontrolled infection or psychiatric illness/social situations that would
             limit compliance with study requirements.

         10. Known hypersensitivity to 5-fluorouracil/leucovorin

         11. Known dihydropyrimidine dehydrogenase (DPD) deficiency

         12. Known hypersensitivity to irinotecan

         13. Chronic inflammatory bowel disease (Crohn's disease or ulcerative colitis)

         14. Patients receiving treatment with St. John's wort or Phenytoin.

         15. Patients who plan to receive yellow fever vaccine during the course of the study
             treatment.

         16. Abnormal glucuronidation of bilirubin, known Gilbert's syndrome

         17. Patients with QTc interval &gt; 470 milliseconds

         18. For patients to be treated with a regimen containing bevacizumab:

               -  History of cardiac disease: congestive heart failure (CHF) &gt; New York Heart
                  Association (NYHA) Class II; active coronary artery disease, myocardial
                  infarction within 6 months prior to study entry; unevaluated new onset angina
                  within 3 months or unstable angina (angina symptoms at rest) or cardiac
                  arrhythmias requiring anti-arrhythmic therapy (beta blockers or digoxin are
                  permitted).

               -  Current uncontrolled hypertension (systolic blood pressure [BP] &gt; 150 mmHg or
                  diastolic pressure &gt; 90 mmHg despite optimal medical management) as well as prior
                  history of hypertensive crisis or hypertensive encephalopathy.

               -  History of arterial thrombotic or embolic events (within 6 months prior to study
                  entry)

               -  Significant vascular disease (e.g., aortic aneurysm, aortic dissection,
                  symptomatic peripheral vascular disease)

               -  Evidence of bleeding diathesis or clinically significant coagulopathy

               -  Major surgical procedure (including open biopsy, significant traumatic injury,
                  etc.) within 28 days, or anticipation of the need for major surgical procedure
                  during the course of the study as well as minor surgical procedure (excluding
                  placement of a vascular access device or bone marrow biopsy) within 7 days prior
                  to study enrollment

               -  Proteinuria at screening as demonstrated by urinalysis with proteinuria ≥ 2+
                  (patients discovered to have ≥2+ proteinuria on dipstick urinalysis at baseline
                  should undergo a 24 hour urine collection and must demonstrate ≤ 1g of protein in
                  24 hours to be eligible).

               -  History of abdominal fistula, gastrointestinal perforation, peptic ulcer, or
                  intra-abdominal abscess within 6 months

               -  Ongoing serious, non-healing wound, ulcer, or bone fracture

               -  Known hypersensitivity to any component of bevacizumab

               -  History of reversible posterior leukoencephalopathy syndrome (RPLS)

               -  History of hypersensitivity to Chinese hamster ovary (CHO) cells or other human
                  or humanized recombinant antibodies.

         19. Patients with a history of other malignancies except: adequately treated non-melanoma
             skin cancer, curatively treated in-situ cancer of the cervix, or other solid tumors
             curatively treated with no evidence of disease for &gt; 3 years.

         20. Any active disease condition which would render the protocol treatment dangerous or
             impair the ability of the patient to receive protocol therapy.

         21. Any condition (e.g. psychological, geographical, etc.) that does not permit compliance
             with the protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Boston Biomedical</last_name>
    <phone>617-674-6800</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Alabama Oncology</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35223</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Arizona</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85054</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie Mihalik</last_name>
      <phone>480-342-3256</phone>
      <email>mihalik.laurie@mayo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Arizona Oncology Associates, PC - HOPE</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85771</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Kirkwood</last_name>
      <phone>281-863-2587</phone>
      <email>Megan.Kirkwood@McKesson.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Comprehensive Blood and Cancer Center</name>
      <address>
        <city>Bakersfield</city>
        <state>California</state>
        <zip>93309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sudha Dara</last_name>
      <phone>661-616-1619</phone>
      <email>sdara@cbccusa.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>City of Hope- Comprehensive Care Center</name>
      <address>
        <city>Duarte</city>
        <state>California</state>
        <zip>91010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heera Pokhrel</last_name>
      <phone>626-218-0171</phone>
      <email>hpokhrel@coh.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California-San Diego/Moores UCSD Cancer Center</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erika Buell</last_name>
      <phone>858-822-5352</phone>
      <email>ebuell@ucsd.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Los Angeles Hematology Oncology Medical Group</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90017</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruma Barva</last_name>
      <phone>213-977-1214</phone>
      <email>rbarva@scoranet.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>USC Norris Comprehensive Cancer Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Garcia Leiva</last_name>
      <phone>232-865-3000</phone>
      <email>maria.garcaileiva@med.usc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UCLA Hematology Oncology Santa Monica</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robin Kemball</last_name>
      <phone>310-825-8195</phone>
      <email>rkemball@mednet.ucla.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Joseph Heritage Healthcare</name>
      <address>
        <city>Santa Rosa</city>
        <state>California</state>
        <zip>95405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Young</last_name>
      <phone>707-521-3814</phone>
      <email>kimberly.young@stjoe.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rocky Mountain Cancer Centers</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Kirkwood</last_name>
      <phone>281-863-2592</phone>
      <email>Megan.Kirkwood@McKesson.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Mary's Hospital &amp; Regional Med Center</name>
      <address>
        <city>Grand Junction</city>
        <state>Colorado</state>
        <zip>81501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Byerly</last_name>
      <phone>970-298-6575</phone>
      <email>amy.byerly@sclhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Oncology Hematology Consultants, PA</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Combs</last_name>
      <phone>302-623-4639</phone>
      <email>kcombs@christianacare.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Florida Cancer Specialists &amp; Research Institute Fort Myers</name>
      <address>
        <city>Fort Myers</city>
        <state>Florida</state>
        <zip>33901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dawn Andrews</last_name>
      <phone>941-730-2025</phone>
      <email>dandrews@flcancer.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Memorial Cancer Institute at Memorial Hospital</name>
      <address>
        <city>Hollywood</city>
        <state>Florida</state>
        <zip>33021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mihaela Roldan</last_name>
      <phone>954-865-1864</phone>
      <email>MiRoldan@mhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baptist Health Medical Group Oncology, LLC</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33176</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolina Manchola-Orozco</last_name>
      <phone>305-595-2141</phone>
      <email>CarolinaMan@baptisthealth.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sarah Cannon Research Institution</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dinah Barnes</last_name>
      <phone>727-216-1143</phone>
      <email>dibarnes@flcancer.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Palm Beach Cancer Institute</name>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <zip>33401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Bar-Nur</last_name>
      <phone>561-472-1696</phone>
      <email>jbar-nur@flcancer.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Piedmont Cancer Institute, PC</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30318</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann Johnston</last_name>
      <phone>678-298-3241</phone>
      <email>ajohnston@piedmontcancerinstitute.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Emory University/Winship Cancer Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meredith Renfroe</last_name>
      <phone>404-778-2670</phone>
      <email>meredith.renfroe@emory.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Suburban Hematology-Oncology Associates, PC - Lawrenceville</name>
      <address>
        <city>Lawrenceville</city>
        <state>Georgia</state>
        <zip>30046</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaneka Douglas</last_name>
      <phone>678-312-3834</phone>
      <email>sdouglas@gwinnettmedicalcenter.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Illinois Cancer Specialists</name>
      <address>
        <city>Arlington Heights</city>
        <state>Illinois</state>
        <zip>60005</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Kirkwood</last_name>
      <phone>281-863-2586</phone>
      <email>Megan.Kirkwood@McKesson.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northshore University Healthsystem</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert March</last_name>
      <phone>847-570-2112</phone>
      <email>marsh@northshore.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Healthcare Research Network III, LLC</name>
      <address>
        <city>Tinley Park</city>
        <state>Illinois</state>
        <zip>60487</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mina Boyadzhieva</last_name>
      <phone>708-745-9971</phone>
      <email>mboyadzhieva@healthcareresearchnetwork.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwestern Medicine Cancer Center</name>
      <address>
        <city>Warrenville</city>
        <state>Illinois</state>
        <zip>60555</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudine Gamster</last_name>
      <phone>630-315-1918</phone>
      <email>Claudine.Gamster@nm.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Parkview Research Center</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46845</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abby Reed</last_name>
      <phone>260-425-6811</phone>
      <email>Abby.reed@parkview.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Indiana University Health Goshen Center for Cancer Care</name>
      <address>
        <city>Goshen</city>
        <state>Indiana</state>
        <zip>46526</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vanessa DePue</last_name>
      <phone>574-364-2649</phone>
      <email>vdepue@goshenhealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Michiana Hematology Oncology, PC</name>
      <address>
        <city>Mishawaka</city>
        <state>Indiana</state>
        <zip>46545</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lori Wiseman</last_name>
      <phone>574-647-6821</phone>
      <email>lwiseman@mhopc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Center of Kansas</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Statesn Davis</last_name>
      <phone>316-613-4318</phone>
      <email>Statesn.davis@cancercenterofkansas.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dana Farber</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samantha Schuetz</last_name>
      <phone>671-632-5575</phone>
      <email>samanthar.schuetz@dfci.harvard.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Umass Memorial Medical Center</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexandra Agrillo</last_name>
      <phone>774-455-4456</phone>
      <email>alexandra.agrillo@umassmed.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Michigan Cancer Center</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Bebee</last_name>
      <phone>734-763-3803</phone>
      <email>pbe@med.umich.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Minnesota Oncology Hematology, P.A.</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Kirkwood</last_name>
      <phone>281-863-2588</phone>
      <email>Megan.Kirkwood@McKesson.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Arizona</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lori Heinrichs</last_name>
      <phone>507-538-8059</phone>
      <email>heinrichs.lori@mayo.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Research Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zac Clifford</last_name>
      <phone>816-276-4459</phone>
      <email>zachary.clifford@hcamidwest.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Missouri Baptist Medical Center ACCRU Network Site</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henry Robinson</last_name>
      <phone>314-996-5569</phone>
      <email>henry.robinson@bjc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Francis Cancer Treatment Center</name>
      <address>
        <city>Grand Island</city>
        <state>Nebraska</state>
        <zip>68803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mehmet Sitki Copur, MD</last_name>
      <phone>308-398-6518</phone>
      <email>clinicaltrials@sfmc-gi.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Missouri Valley Cancer Consortium</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Wilwerding</last_name>
      <phone>402-991-8070</phone>
      <phone_ext>202</phone_ext>
      <email>mwilwerding@mvcc.cc</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Research Network of Nebraska / Oncology Associates PC</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Tennessee Oncology PLLC</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Daly</last_name>
      <phone>423-702-7897</phone>
      <email>melissa.daly@scresearch.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Darthmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Tarczewski</last_name>
      <phone>603-650-6380</phone>
      <email>susan.m.tarczewski@hitchcock.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Carol G. Simon Cancer Center</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07962</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Mackenzie</last_name>
      <phone>973-436-1755</phone>
      <email>mmackenzie@smgnj.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of New Mexico</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denise Buchanan</last_name>
      <phone>505-385-8027</phone>
      <email>buchclan@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jyoti Pooja</last_name>
      <phone>480-342-3256</phone>
      <email>jpooja@montefiore.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Roswell Park Cancer Center</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14263</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suman Sarker</last_name>
      <phone>716-845-4886</phone>
      <email>suman.sarker@roswellpark.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>North Shore Hematology Oncology Associates</name>
      <address>
        <city>East Setauket</city>
        <state>New York</state>
        <zip>11733</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Don Marx</last_name>
      <phone>631-675-5143</phone>
      <email>dmarx@nycancer.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tong Dai</last_name>
      <phone>646-962-6200</phone>
      <email>dai2015@med.cornell.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Southeastern Medical Oncology Center</name>
      <address>
        <city>Goldsboro</city>
        <state>North Carolina</state>
        <zip>27534</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharon Grantham</last_name>
      <phone>919-580-0000</phone>
      <email>sgrantham@cancersmoc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Gilliam</last_name>
      <phone>336-713-6912</phone>
      <email>lgilliam@wakehealth.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Toledo Clinic Cancer Centers</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43623</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pam Shoup</last_name>
      <phone>419-214-4236</phone>
      <email>pshoup@toledoclinic.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Geisinger Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Snyder</last_name>
      <phone>570-271-2611</phone>
      <email>hsnyder@geisinger.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>VA Pittsburgh Healthcare System</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15240</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharlene Wylie</last_name>
      <phone>412-360-6230</phone>
      <email>sharlene.wylie@va.gov</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29412</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Drew Longshore</last_name>
      <phone>843-792-4271</phone>
      <email>longshor@musc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sanford Cancer Center</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Olson</last_name>
      <phone>605-328-1388</phone>
      <email>catherine.olson@sanfordhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Tennessee Medical Center</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37920</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brandy Herbert</last_name>
      <phone>865-305-5120</phone>
      <email>bherbert@utmck.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>West Cancer Center</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ghazala Mazhar, MD</last_name>
      <phone>901-683-0085</phone>
      <phone_ext>61227</phone_ext>
      <email>gmazhar@westclinic.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Sarah Cannon Research Institute</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Marx</last_name>
      <phone>615-289-9205</phone>
      <email>scott.marx@sarahcannon.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Texas Oncology-Austin Midtown</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>75705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Kirkwood</last_name>
      <phone>281-863-2586</phone>
      <email>Megan.Kirkwood@McKesson.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Texas Oncology - Dallas Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debora Jimerson</last_name>
      <phone>972-780-3406</phone>
      <email>debora.jimerson@usoncology.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Texas Oncology - Denton South</name>
      <address>
        <city>Denton</city>
        <state>Texas</state>
        <zip>76210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Kirkwood</last_name>
      <phone>281-863-2589</phone>
      <email>Megan.Kirkwood@McKesson.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Texas Oncology - Fort Worth</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Kirkwood</last_name>
      <phone>281-863-2586</phone>
      <email>Megan.Kirkwood@McKesson.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Millenium Oncology</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77090</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Waldron</last_name>
      <phone>877-870-2640</phone>
      <email>JWaldron@wmrad.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Texas Health Physicians Group</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzette Clark</last_name>
      <phone>972-428-4931</phone>
      <email>suzetteclark@texashealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Texas Oncology-San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78217</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Kirkwood</last_name>
      <phone>281-863-2586</phone>
      <email>Megan.Kirkwood@McKesson.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Texas Oncology - Tyler</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75702</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Kirkwood</last_name>
      <phone>281-863-2586</phone>
      <email>Megan.Kirkwood@McKesson.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Texas Oncology - Wichita Falls Texoma Cancer Center</name>
      <address>
        <city>Wichita Falls</city>
        <state>Texas</state>
        <zip>76310</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Kirkwood</last_name>
      <phone>281-863-2590</phone>
      <email>Megan.Kirkwood@McKesson.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northern Utah Associates</name>
      <address>
        <city>Ogden</city>
        <state>Utah</state>
        <zip>84403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shirley Waters</last_name>
      <phone>801-387-7166</phone>
      <email>nua.shirley@nmail.email</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>US Oncology - Virginia Cancer Specialists, PC</name>
      <address>
        <city>Fairfax</city>
        <state>Virginia</state>
        <zip>22031</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karin Choquette</last_name>
      <phone>571-389-0873</phone>
      <email>karin.choquette@USOncology.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fort Belvoir Community Hospital</name>
      <address>
        <city>Fort Belvoir</city>
        <state>Virginia</state>
        <zip>22060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Greneisha T Jackson</last_name>
      <phone>571-231-3491</phone>
      <email>greneisha.t.jackson.ctr@mail.mil</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Virginia Oncology Associates</name>
      <address>
        <city>Hampton</city>
        <state>Virginia</state>
        <zip>23666</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Kirkwood</last_name>
      <phone>281-863-2591</phone>
      <email>Megan.Kirkwood@McKesson.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Blue Ridge Cancer Care</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24014</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Virginia Mason</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ibrahim Abukenda</last_name>
      <phone>206-287-1049</phone>
      <email>ibrahim.abukenda@virginiamason.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seattle Cancer Care Alliance</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98109-1023</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristen Rivera</last_name>
      <phone>206-606-7350</phone>
      <email>krivera@seattlecca.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwest Cancer Specialists, P.C.</name>
      <address>
        <city>Vancouver</city>
        <state>Washington</state>
        <zip>98684</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Megan Kirkwood</last_name>
      <phone>281-863-2586</phone>
      <email>Megan.Kirkwood@McKesson.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bankstown-Lidcombe Hospital</name>
      <address>
        <city>Bankstown</city>
        <state>New South Wales</state>
        <zip>2200</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mafizul Hoque</last_name>
      <phone>+61-2-9722-8622</phone>
      <email>mafizul.hoque@sswahs.nsw.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Vincent's Hospital</name>
      <address>
        <city>Darlinghurst</city>
        <state>New South Wales</state>
        <zip>2010</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lalith Ratnayake</last_name>
      <phone>+61-2-9355-5615</phone>
      <email>Lalith.Ratnayake@svha.org.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Vincent's hospital Melbourne</name>
      <address>
        <city>Fitzroy</city>
        <state>New South Wales</state>
        <zip>3065</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadia Ranieri</last_name>
      <phone>+61-3-9288-3167</phone>
      <email>Nadia.ranieri@svha.org.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Port Macquaries Base Hospital</name>
      <address>
        <city>Port Macquarie</city>
        <state>New South Wales</state>
        <zip>2444</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suzzanna Fettell</last_name>
      <phone>+61-2-6580-1822</phone>
      <email>suzzanna.fettell@ncahs.health.nsw.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal North Shore Hospital</name>
      <address>
        <city>St Leonards</city>
        <state>New South Wales</state>
        <zip>2065</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Poechhacker</last_name>
      <phone>+61-2-8037-4100</phone>
      <email>spoechhacker@northerncancerinstitute.com.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sunshine Coast Hospital and Health Service</name>
      <address>
        <city>Nambour</city>
        <state>Queensland</state>
        <zip>4560</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Simmons</last_name>
      <phone>+617 5202 0651</phone>
      <email>OncologyTrials@health.qld.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gold Coast University Hosptial</name>
      <address>
        <city>Southport</city>
        <state>Queensland</state>
        <zip>4215</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacob Darch</last_name>
      <phone>+61-7-5687-2712</phone>
      <email>jacob.darch@health.qld.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Flinders Medical Centre</name>
      <address>
        <city>Bedford Park</city>
        <state>South Australia</state>
        <zip>5042</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Mead</last_name>
      <phone>+61 8 8204 6151</phone>
      <email>Kelly.Mead@sa.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Queen Elizabeth Hospital</name>
      <address>
        <city>Woodville</city>
        <state>South Australia</state>
        <zip>5011</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Egan</last_name>
      <phone>+61-8-8222-7411</phone>
      <email>elizabeth.egan@sa.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bendigo Hospital</name>
      <address>
        <city>Bendigo</city>
        <state>Victoria</state>
        <zip>3550</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Clark</last_name>
      <phone>+61-3-5454-7210</phone>
      <email>amyclark@bendigohealth.org.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peninsula &amp; South Eastern Haematology and Oncology Group</name>
      <address>
        <city>Frankston</city>
        <state>Victoria</state>
        <zip>3199</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Albert Goikhman</last_name>
      <phone>+61-3-9771-8907</phone>
      <email>ag@paso.com.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Austin Hospital</name>
      <address>
        <city>Heidelberg</city>
        <state>Victoria</state>
        <zip>3084</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donna Haberl</last_name>
      <phone>+61-3-9496-5316</phone>
      <email>donna.haberl@austin.org.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Western Health</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3021</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Hadfield</last_name>
      <phone>+613 8395 9168</phone>
      <email>Maria.Hadfield@wh.org.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Goulburn Valley Health</name>
      <address>
        <city>Shepparton</city>
        <state>Victoria</state>
        <zip>3630</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carole Mott</last_name>
      <phone>+613 5832 3778</phone>
      <email>oncologyclinicaltrials@gvhealth.org.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Imelda Ziekenhuis</name>
      <address>
        <city>Bonheiden</city>
        <state>Antwerpen</state>
        <zip>2820</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Doreen Iwens</last_name>
      <phone>+32 15 50 47 10</phone>
      <email>doreen.iwens@imelda.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Imelda Ziekenhuis</name>
      <address>
        <city>Bonheiden</city>
        <state>Antwerpen</state>
        <zip>2821</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Doreen Iwens</last_name>
      <phone>+32 15 50 47 11</phone>
      <email>doreen.iwens@imelda.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Imelda Ziekenhuis</name>
      <address>
        <city>Bonheiden</city>
        <state>Antwerpen</state>
        <zip>2822</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Doreen Iwens</last_name>
      <phone>+32 15 50 47 12</phone>
      <email>doreen.iwens@imelda.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AZ Turnhout - Campus Sint-Elisabeth</name>
      <address>
        <city>Turnhout</city>
        <state>Antwerpen</state>
        <zip>2300</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nel Bovin</last_name>
      <phone>+32 14 40 69 08</phone>
      <email>nel.bovin@azturnhout.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Erasme</name>
      <address>
        <city>Bruxelles</city>
        <state>Brussels Capital Region</state>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mia Persoons</last_name>
      <phone>+32 25 55 30 16</phone>
      <email>mia.persoons@erasme.ulb.ac.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Grand Hôpital de Charleroi - Site Notre-Dame</name>
      <address>
        <city>Charleroi</city>
        <state>Hainaut</state>
        <zip>6000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janique Dewelle</last_name>
      <phone>+32 71 10 47 09</phone>
      <email>janique.dewelle@ghdc.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Liège - Domaine Universitaire du Sart Tilman</name>
      <address>
        <city>Bruxelles</city>
        <state>Liège</state>
        <zip>1050</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Evrard</last_name>
      <phone>+32 42 84 38 11</phone>
      <email>linda.evrard@chu.ulg.ac.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UZ Leuven - Campus Gasthuisberg</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hilde Marsé</last_name>
      <phone>+32 16 34 75 83</phone>
      <email>hilde.marse@uzleuven.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AZ Sint-Jan Brugge - Oostende - Campus Sint-Jan</name>
      <address>
        <city>Brugge</city>
        <state>West-Vlaanderen</state>
        <zip>8000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Van Massenhove</last_name>
      <phone>+32 50 45 25 54</phone>
      <email>deborah.vanmassenhove@azsintjan.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AZ Sint-Lucas - Campus Sint-Lucas</name>
      <address>
        <city>Brugge</city>
        <state>West-Vlaanderen</state>
        <zip>8310</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tania Maerten</last_name>
      <phone>+32 50 36 90 57</phone>
      <email>tania.maerten@stlucas.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tom Baker Cancer Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4N2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Ng</last_name>
      <phone>403-521-3925</phone>
      <email>amy.ng02@albertahealthservices.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Ottawa Hospital Cancer Centre</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1H 8L6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Henderson</last_name>
      <phone>613-737-7700</phone>
      <phone_ext>70550</phone_ext>
      <email>ahenderson@toh.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Toronto - Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kate Besel</last_name>
      <phone>416-480-5000</phone>
      <phone_ext>7868</phone_ext>
      <email>kate.besel@sunnybrook.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint Michael's Hospital Li Ka Shing Knowledge Institute</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5B 1W8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Skitch</last_name>
      <phone>416-864-6060</phone>
      <phone_ext>2084</phone_ext>
      <email>skitcha@smh.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Mary's Hospital Center</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H3T 1M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jajesh Sharma</last_name>
      <phone>514-345-3511</phone>
      <phone_ext>3981</phone_ext>
      <email>jajesh.sharma.comti@ssss.gouv.qc.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Notre-Dame du CHUM</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>HZL 4M1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Gosselin</last_name>
      <phone>514-890-8000</phone>
      <phone_ext>24532</phone_ext>
      <email>julie.gosselin.chum@ssss.gouv.qc.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing Cancer Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100142</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Henan Cancer Hospital</name>
      <address>
        <city>Henan</city>
        <zip>450008</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Jiangsu Province Hospital</name>
      <address>
        <city>Jiangsu</city>
        <zip>210029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>FN Hradec Kralove</name>
      <address>
        <city>Hradec Králové</city>
        <state>Královéhradecký Kraj</state>
        <zip>500 05</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simona Sediva</last_name>
      <phone>+420-495-832-489</phone>
      <email>simona.sediva@fnhk.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Masarykuv onkologicky ustav</name>
      <address>
        <city>Brno</city>
        <zip>656 53</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petra Sevelova</last_name>
      <phone>+420-543-136-220</phone>
      <email>petra.sevelova@mou.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Masarykuv onkologicky ustav</name>
      <address>
        <city>Brno</city>
        <zip>656 53</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petra Sevelova</last_name>
      <phone>+420 543 136 220</phone>
      <email>petra.sevelova@mou.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Leopoldina Krankenhaus Med. Klinik 2</name>
      <address>
        <city>Schweinfurt</city>
        <state>Bayern</state>
        <zip>97422</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katja Richter</last_name>
      <phone>+49-97-217-2024-11</phone>
      <email>krichter@leopoldina.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Schwerpunkpraxis für Hämatologie und Onkologie</name>
      <address>
        <city>Magdeburg</city>
        <state>Sachsen-Anhalt</state>
        <zip>39104</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Statesnne Kroening</last_name>
      <phone>+49-3915616568</phone>
      <email>Statesnne.kroening@onkologie-magdeburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Carl Gustav Carus Dresden</name>
      <address>
        <city>Dresden</city>
        <state>Sachsen</state>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evelyn Franke</last_name>
      <phone>+49-351-458-6335</phone>
      <email>evelyn.franke@uniklinikum-dresden.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vivantes Klinikum Am Urban</name>
      <address>
        <city>Berlin</city>
        <zip>10967</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anja Müller</last_name>
      <phone>+49-30-130-2221-60</phone>
      <email>anja.mueller5@vivantes.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Charite - Campus Benjamin Franklin (Cbf)</name>
      <address>
        <city>Berlin</city>
        <zip>12203</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabine Krause</last_name>
      <phone>+49-30-8445-4708</phone>
      <email>sabine.krause@charite.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>DRK Kliniken Berlin Koepenick</name>
      <address>
        <city>Berlin</city>
        <zip>12559</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antje Kallel</last_name>
      <phone>+49-30-3035-3387</phone>
      <email>a.kallel@drk-kliniken-berlin.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>MVZ Onkologischer Schwerpunkt am Oskar-Helene-Heim</name>
      <address>
        <city>Berlin</city>
        <zip>14195</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Swetlana Wahnke</last_name>
      <phone>+49-30-644-9952-27</phone>
      <email>akirsch99@t-online.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Facharztzentrum Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20249</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Detlef-Andreas Fabian</last_name>
      <phone>+49-40-41467893</phone>
      <email>studienzentrale@onkologie-eppendorf.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pamela Youde Nethersole Eastern Hospital</name>
      <address>
        <city>Hong Kong</city>
        <zip>150001</zip>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mandy Wong</last_name>
      <phone>+852 2595 4183</phone>
      <email>wym849@ha.org.hk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queen Mary Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Winnie Chan</last_name>
      <phone>+852 2255 4361</phone>
      <email>winc@hku.hk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queen Mary Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandy Cheung</last_name>
      <phone>+852 2255 5034</phone>
      <email>sandy718@hku.hk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AOU Ospedali Riuniti Umberto I - GM.Lanc</name>
      <address>
        <city>Torrette Di Ancona</city>
        <state>Ancona</state>
        <zip>60126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rossana Berardi</last_name>
      <phone>+390715965093</phone>
      <email>rossana.berardi@ospedaliriuniti.marche.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Santa Maria del Prato</name>
      <address>
        <city>Feltre</city>
        <state>Belluno</state>
        <zip>32032</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Davide Pastorelli</last_name>
      <phone>+390439883304</phone>
      <email>davide.pastorelli@ulssfeltre.veneto.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Irccs Irst</name>
      <address>
        <city>Meldola</city>
        <state>Forli</state>
        <zip>47014</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Flavia Pagan</last_name>
      <phone>+39-0543-739423</phone>
      <email>flavia.pagan@irst.emr.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AUSL della Romagna, Osp. degli Infermi</name>
      <address>
        <city>Faenza</city>
        <state>Ravenna</state>
        <zip>48018</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandra Piancastelli</last_name>
      <phone>+390546601194</phone>
      <email>alessandra.piancastelli@irst.emr.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinico S.Orsola Malpighi, AOU di Bologna</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Ardizzoni</last_name>
      <phone>+390516362206</phone>
      <email>oncotrials.bologna@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>PO di Cremona, ASST di Cremona</name>
      <address>
        <city>Cremona</city>
        <zip>26100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gianluca Tomasello</last_name>
      <phone>+390372405248</phone>
      <email>g.tomasello@asst-cremona.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AO S. Martino, IRCCS, IST</name>
      <address>
        <city>Genova</city>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Sobrero</last_name>
      <phone>+390105554386</phone>
      <email>alberto.sobrero@hsanmartino.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ieo, Irccs</name>
      <address>
        <city>Milano</city>
        <zip>20141</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Giulia Zampino</last_name>
      <phone>+390257489406</phone>
      <email>maria.zampino@ieo.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AOU Policlinico di Modena</name>
      <address>
        <city>Modena</city>
        <zip>41124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriele Luppi</last_name>
      <phone>+39059424383</phone>
      <email>gabriele.luppi@tin.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Università degli studi della Campania &quot;L.Vanvitelli&quot;</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fortunato Ciardiello</last_name>
      <phone>+390815666760</phone>
      <email>fortunato.ciardiello@unicampania.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Guglielmo da Saliceto, AUSL Piacenza</name>
      <address>
        <city>Piacenza</city>
        <zip>29121</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luigi Cavanna</last_name>
      <phone>+390523302697</phone>
      <email>l.cavanna@ausl.pc.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aichi Cancer Center Hospital</name>
      <address>
        <city>Nagoya</city>
        <state>Aichi</state>
        <zip>464-8681</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Cancer Center Hospital East</name>
      <address>
        <city>Kashiwa</city>
        <state>Chiba</state>
        <zip>277-8577</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Shikoku Cancer Center</name>
      <address>
        <city>Matsunami</city>
        <state>Ehime</state>
        <zip>791-0280</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hokkaido University Hospital</name>
      <address>
        <city>Sapporo</city>
        <state>Hokkaido</state>
        <zip>060-8648</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kobe City Medical Center General Hospital</name>
      <address>
        <city>Kobe</city>
        <state>Hyogo</state>
        <zip>650-0047</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>ST. Marianna University School of Medicine</name>
      <address>
        <city>Kawasaki</city>
        <state>Kanagawa</state>
        <zip>216-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Osaka University Hospital</name>
      <address>
        <city>Suita</city>
        <state>Osaka</state>
        <zip>565-0871</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Osaka Medical College Hospital</name>
      <address>
        <city>Takatsuki</city>
        <state>Osaka</state>
        <zip>569-8686</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Saitama Cancer Center</name>
      <address>
        <city>Kita-Adachi</city>
        <state>Saitama</state>
        <zip>362-0806</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Shizuoka Cancer Center</name>
      <address>
        <city>Sunto</city>
        <state>Shizuoka</state>
        <zip>411-8777</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Medical Hospital, Tokyo Medical and Dental University</name>
      <address>
        <city>Bunkyo-ku</city>
        <state>Tokyo</state>
        <zip>113-8510</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Cancer Center Hospital</name>
      <address>
        <city>Chuo-ku</city>
        <state>Tokyo</state>
        <zip>104-0045</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The cancer insitute hospital of JFCR (Japanese Foundation For Cancer Research)</name>
      <address>
        <city>Koto-ku</city>
        <state>Tokyo</state>
        <zip>135-8550</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Kyushu Cancer Center</name>
      <address>
        <city>Fukuoka</city>
        <zip>811-1395</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Osaka Medical Center for Cancer and Cardiovascular Diseases</name>
      <address>
        <city>Osaka</city>
        <zip>537-8511</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Osaka National Hospital</name>
      <address>
        <city>Osaka</city>
        <zip>540-0006</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Yeungnam University Medical Center</name>
      <address>
        <city>Daegu</city>
        <state>Daegu Gwang'yeogsi</state>
        <zip>42415</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mi-Jung 미정 Kim 김</last_name>
      <phone>+82-53-620-3204</phone>
      <email>imh01@ymc.yu.ac.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Cancer Centre</name>
      <address>
        <city>Goyang</city>
        <state>Gyeonggido</state>
        <zip>10408</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eun Kyung 은경 Shim 심</last_name>
      <phone>+82-31-920-1145</phone>
      <email>dieforsky@ncc.re.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ajou University Hospital</name>
      <address>
        <city>Suwon</city>
        <state>Gyeonggido</state>
        <zip>16499</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ju Young 주영 Shin 신</last_name>
      <phone>+82-31-219-4402</phone>
      <email>gilinana@aumc.ac.kr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gachon University Gil Medical Center</name>
      <address>
        <city>Incheon</city>
        <state>Incheon Gwang'yeogsi</state>
        <zip>21565</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yeon Jung 연정 Choi 최</last_name>
      <phone>+82-32-460-3231</phone>
      <email>ynian2016@naver.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Korea University Anam Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Seoul Teugbyeolsi</state>
        <zip>02841</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sejung 세정 Moon 문</last_name>
      <phone>+82-2-920-6950</phone>
      <email>msoy12@daum.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <state>Seoul Teugbyeolsi</state>
        <zip>06351</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Inbi Park</last_name>
      <phone>+82-2-3410-6483</phone>
      <email>inbi.park@samsung.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Korea University Guro Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Seoul Teugbyeolsi</state>
        <zip>08308</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sae Young 세영 Kang 강</last_name>
      <phone>+82-2-2626-2218</phone>
      <email>sezero79@naver.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Severance Hospital, Yonsei University Health System</name>
      <address>
        <city>Seoul</city>
        <state>Seoul Teugbyeolsi</state>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyon Jung Park</last_name>
      <phone>+82-2-2228-8054</phone>
      <email>hjwwjd@yuhs.ac</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medisch Centrum Leeuwarden</name>
      <address>
        <city>Leeuwarden</city>
        <state>Friesland</state>
        <zip>8934 AD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tineke Rienks</last_name>
      <phone>+31-58-286-6666</phone>
      <email>tineke.rienks@znb.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Academisch Medisch Centrum</name>
      <address>
        <city>Amsterdam</city>
        <zip>1055 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lyda ter Hofstede</last_name>
      <phone>+31 205668229</phone>
      <email>trialmedonc@amc.uva.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Spaarne Gasthuis</name>
      <address>
        <city>Hoofddorp</city>
        <zip>2134 TM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dea Storm</last_name>
      <phone>+31 232245802</phone>
      <email>researchinterne@spaarnegasthuis.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maastricht UMC</name>
      <address>
        <city>Maastricht</city>
        <zip>6229 HX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elles Lenaerts</last_name>
      <phone>+31 433871197</phone>
      <email>trialbureau.medischeoncologie@mumc.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Elizabeth Tweesteden Ziekenhuis locatie Tilburg</name>
      <address>
        <city>Tilburg</city>
        <zip>5042 SB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emile Maassen</last_name>
      <phone>+31-13-465-5234</phone>
      <email>onco-research@tsz.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National University Cancer Institute</name>
      <address>
        <city>Singapore</city>
        <state>Central Singapore</state>
        <zip>119228</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wan Ying Koh</last_name>
      <phone>+65-6772-6794</phone>
      <email>wan_ying_koh@nuhs.edu.sg</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Cancer Centre</name>
      <address>
        <city>Singapore</city>
        <state>Central Singapore</state>
        <zip>169610</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Raffles Hospital</name>
      <address>
        <city>Singapore</city>
        <state>Central Singapore</state>
        <zip>188770</zip>
        <country>Singapore</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christie Yang</last_name>
      <phone>+65-6311-2305</phone>
      <email>yang_christie@rafflesmedical.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Elche</name>
      <address>
        <city>Elche</city>
        <state>Alicante</state>
        <zip>3203</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Javier Gallego Plazas</last_name>
      <phone>3496 661 62 50</phone>
      <email>j.gallegoplazas@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>H.U.V. del Rocío</name>
      <address>
        <city>Sevilla</city>
        <state>Andalucía</state>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valladares Ayerbes Manuel</last_name>
      <phone>34 660941595</phone>
      <email>mvalaye@icloud.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <state>Asturias</state>
        <zip>33011</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José María Vieitez</last_name>
      <phone>34985106121</phone>
      <email>josemariavieitez@yahoo.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Català d'Oncologia-Hospital Universitari Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <zip>8916</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Buges Sanchez</last_name>
      <phone>34934978925</phone>
      <email>cbuges@iconcologia.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Complexo Hospital Universitario A Coruña</name>
      <address>
        <city>A Coruña</city>
        <state>Galicia</state>
        <zip>15006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margarita Roboredo</last_name>
      <phone>34981178000</phone>
      <email>margarita.reboredo.lopez@sergas.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Fundacion Alcorcon (HUFA)</name>
      <address>
        <city>Alcorcón</city>
        <state>Madrid</state>
        <zip>28922</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Carlos Camara Vicario</last_name>
      <phone>34916219490</phone>
      <email>jccamara@fhalcorcon.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Puerta de Hierro-Majadahonda</name>
      <address>
        <city>Majadahonda</city>
        <state>Madrid</state>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Ruiz Casado</last_name>
      <phone>34911916671</phone>
      <email>arcasado@salud.madrid.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Consorci Hospital General Universitari Valencia (CHGUV)</name>
      <address>
        <city>Comunidad Valenciana</city>
        <state>Valencia</state>
        <zip>46014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria José Safont</last_name>
      <phone>34963131800</phone>
      <email>mjsafont@yahoo.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Son Llatzer</name>
      <address>
        <city>Baleares</city>
        <zip>7198</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Falcó Ferrer Esther</last_name>
      <phone>34871202000</phone>
      <phone_ext>1264</phone_ext>
      <email>efalco@hsll.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Vall d'Hebrón</name>
      <address>
        <city>Barcelona</city>
        <zip>080035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ízar Achaerandio</last_name>
      <phone>+34-93-489-43-75</phone>
      <email>iachaerandio@vhio.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joana Vidal Barrull</last_name>
      <phone>34932483000</phone>
      <email>99938@parcdesalutmar.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic i Provincial de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>8036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>34 93 227 54 02</phone>
      <email>jmaurel@clinic.ub.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <zip>28016</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pilar García Alfonso</last_name>
      <phone>34914265207</phone>
      <email>pgarcaalfonso@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sastre Valera Javier</last_name>
      <phone>34913303546</phone>
      <phone_ext>7545</phone_ext>
      <email>jsastrev@salud.madrid.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>García Carbonero Rocío</last_name>
      <phone>34913908922</phone>
      <email>rgcarbonero@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nuria Rodríguez Salas</last_name>
      <phone>3491 7277000</phone>
      <email>nuria.rodriguez@salud.madrid.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de la Arrixaca</name>
      <address>
        <city>Murcia</city>
        <zip>30120</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel Marin Vera</last_name>
      <phone>34986369516</phone>
      <email>miguelmarin75@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de la Macarena</name>
      <address>
        <city>Sevilla</city>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reina Zoilo Juan</last_name>
      <phone>34955926578</phone>
      <email>juanjoreinaz@yahoo.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>H.C.U.Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cervantes Ruipérez Andrés</last_name>
      <phone>34963862625</phone>
      <email>andres.cervantes@uv.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alonso Orduña Vicente</last_name>
      <phone>34976765500</phone>
      <phone_ext>3825</phone_ext>
      <email>alonord@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>China</country>
    <country>Czechia</country>
    <country>Germany</country>
    <country>Hong Kong</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Korea, Republic of</country>
    <country>Netherlands</country>
    <country>Singapore</country>
    <country>Spain</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2016</study_first_submitted>
  <study_first_submitted_qc>April 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 27, 2016</study_first_posted>
  <last_update_submitted>December 12, 2017</last_update_submitted>
  <last_update_submitted_qc>December 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Colorectal Neoplasms</keyword>
  <keyword>Colonic Diseases</keyword>
  <keyword>Digestive System Diseases</keyword>
  <keyword>Digestive System Neoplasms</keyword>
  <keyword>Gastrointestinal Diseases</keyword>
  <keyword>Gastrointestinal Neoplasms</keyword>
  <keyword>Intestinal Diseases</keyword>
  <keyword>Intestinal Neoplasms</keyword>
  <keyword>Neoplasms</keyword>
  <keyword>Neoplasms by Histologic Type</keyword>
  <keyword>Neoplasms by Site</keyword>
  <keyword>Neoplasms, Glandular and Epithelial</keyword>
  <keyword>Rectal Diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bevacizumab</mesh_term>
    <mesh_term>Irinotecan</mesh_term>
    <mesh_term>Camptothecin</mesh_term>
    <mesh_term>Fluorouracil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

